WSG selected Flex Databases eTMF & CTMS to centralize and optimize study management
WSG selected Flex Databases eTMF & CTMS to centralize and optimize study management.
We’re excited to announce a new client – a US-based biotech iRenix Medical. Earlier this year, iRenix team selected Flex Databases as an eTMF provider.
We’ve asked Stephen J. Smith, MD, Founder and CEO at iRenix Medical a couple of questions about the upcoming partnership:
Why iRenix Medical decided to implement eTMF module? What was the starting point for digitalization?
iRenix is committed to improving ophthalmic patient care. A key part of achieving this mission is completing high quality clinical trials that can be used to support FDA registration of key products in development. Using an eTMF allows us to achieve compliance with key regulations while also supporting multi-center clinical trials.
Why did you select Flex Databases to be your software provider?
iRenix selected Flex Databases after a thorough review of their system and comparison to competitors. The reviews and demos made us comfortable that this system offered key functionality in an easy-to-use interface for our staff and clinical trial sites.
What do you expect to achieve with the implementation of Flex Databases?
iRenix expects to have a seamless integration of this system into our clinical trial workflow, with excellent system support throughout the duration of our clinical trials.
